Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
暂无分享,去创建一个
V. Paton | M. Merchant | P. Luhn | S. Phan | J. Hsu | Wei Yu | Q. Xia | R. Morley | D. Koralek | A. Cardenas | Yasuyo Suzuki | Wassim Aldairy | P. Hawkins | Alison Cardenas